ARTICLE | Company News
Kinexis, Merck deal
July 28, 2003 7:00 AM UTC
The companies partnered to validate and screen small molecules against a prokineticin receptor target from Kinexis, for use in developing CNS therapeutics. Kinexis will receive research funding and is...